These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3729976)
1. Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters. Larrey D; Tinel M; Letteron P; Geneve J; Descatoire V; Pessayre D Biochem Pharmacol; 1986 Jul; 35(13):2213-20. PubMed ID: 3729976 [TBL] [Abstract][Full Text] [Related]
2. Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Danan G; Descatoire V; Pessayre D J Pharmacol Exp Ther; 1981 Aug; 218(2):509-14. PubMed ID: 7252850 [TBL] [Abstract][Full Text] [Related]
3. Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans. Pessayre D; Larrey D; Vitaux J; Breil P; Belghiti J; Benhamou JP Biochem Pharmacol; 1982 May; 31(9):1699-704. PubMed ID: 6980648 [TBL] [Abstract][Full Text] [Related]
4. Formation of complexes between microsomal cytochrome P-450-Fe(II) and nitrosoarenes obtained by oxidation of arylhydroxylamines or reduction of nitroarenes in situ. Mansuy D; Beaune P; Cresteil T; Bacot C; Chottard JC; Gans P Eur J Biochem; 1978 May; 86(2):573-9. PubMed ID: 26570 [TBL] [Abstract][Full Text] [Related]
5. Interaction of benzanthrone with cytochrome P450: altered patterns of hepatic xenobiotic metabolism in rats. Das M; Garg K; Joshi A; Singh GB; Khanna SK J Biochem Toxicol; 1991; 6(1):37-44. PubMed ID: 1880787 [TBL] [Abstract][Full Text] [Related]
6. Effect of cytochrome P-450 and flavin-containing monooxygenase modifying factors on the in vitro metabolism of amiodarone by rat and rabbit. Young RA; Mehendale HM Drug Metab Dispos; 1987; 15(4):511-7. PubMed ID: 2888625 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin. Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109 [TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
9. SKF 525-A inhibition, induction, and 452-nm complex formation. Buening MK; Franklin MR Drug Metab Dispos; 1976; 4(3):244-55. PubMed ID: 6229 [TBL] [Abstract][Full Text] [Related]
10. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety. Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333 [TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of the antidepressant tianeptine. I. Cytochrome P-450-mediated in vitro covalent binding. Letteron P; Descatoire V; Tinel M; Maurel P; Labbe G; Loeper J; Larrey D; Freneaux E; Pessayre D Biochem Pharmacol; 1989 Oct; 38(19):3241-6. PubMed ID: 2818623 [TBL] [Abstract][Full Text] [Related]
12. Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat. Svensson CK; Liu LL; Knowlton PW Pharm Res; 1987 Jun; 4(3):251-4. PubMed ID: 3509291 [TBL] [Abstract][Full Text] [Related]
13. The mechanism of the suicidal, reductive inactivation of microsomal cytochrome P-450 by carbon tetrachloride. Manno M; De Matteis F; King LJ Biochem Pharmacol; 1988 May; 37(10):1981-90. PubMed ID: 3377806 [TBL] [Abstract][Full Text] [Related]
14. Effect of amiodarone on the disposition of acetaminophen in the rat. Svensson CK; Chong MT J Pharm Sci; 1989 Nov; 78(11):900-2. PubMed ID: 2621571 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite. Nattel S J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817 [TBL] [Abstract][Full Text] [Related]
16. Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs. Bensoussan C; Delaforge M; Mansuy D Biochem Pharmacol; 1995 Mar; 49(5):591-602. PubMed ID: 7887973 [TBL] [Abstract][Full Text] [Related]
17. Nitrosoalkanes as Fe(II) ligands in the 455-nm-absorbing cytochrome P-450 complexes formed from nitroalkanes in reducing conditions. Mansuy D; Gans P; Chottard JC; Bartoli JF Eur J Biochem; 1977 Jun; 76(2):607-15. PubMed ID: 891529 [TBL] [Abstract][Full Text] [Related]
18. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats. Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816 [TBL] [Abstract][Full Text] [Related]
19. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes. Murray M; Hetnarski K; Wilkinson CF Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165 [TBL] [Abstract][Full Text] [Related]
20. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster. Wroblewski VJ; Gessner T; Olson JR Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]